Non-Interventional Study With LYRICA [pregabalin] In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency.

Trial Profile

Non-Interventional Study With LYRICA [pregabalin] In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2010

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 22 May 2009 Planned number of patients changed from 200 to 199 as reported by ClinicalTrials.gov.
    • 22 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top